# Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study

**Authors:** Christina Weyer-Jamora, Melissa S Brie, Paige M Bracci, Ellen M Smith, Tracy L Luks, Stephanie Phan, Steve E Braunstein, Nancy Ann Oberheim-Bush, Nicholas A Butowski, Jennifer L Clarke, Karin Gehring, Adrian Aguilera, John de Groot, Susan M Chang, Shawn L Hervey-Jumper, Jennie W Taylor

PMC · DOI: 10.1093/nop/npaf073 · 2025-07-29

## TL;DR

This study explores whether tele-cognitive rehabilitation can help adults with lower-grade gliomas improve cognitive function, finding that one method (GMT) shows promise while others face challenges.

## Contribution

The study introduces tele-cognitive rehabilitation as a feasible and potentially effective intervention for cognitive impairments in lower-grade glioma patients.

## Key findings

- GMT showed adequate feasibility and satisfaction with 82% adherence and high satisfaction scores.
- Working memory improved in 26% of GMT participants from baseline to postintervention.
- Texting and ReMind had lower adherence and satisfaction compared to GMT.

## Abstract

Cognitive impairments are common in lower-grade gliomas (grades 1–3), but treatment options are limited. Tele-cognitive rehabilitation offers a potential solution. We conducted an interim pilot study to assess the feasibility, satisfaction, and early efficacy of tele-cognitive rehabilitation.

We enrolled adults with stable LrGG (≥6 months posttreatment) who had subjective and objective cognitive impairments (>1 SD below-average in ≥2 domains). Participants received 3 months of individual Goal Management Training (GMT), app-based ReMind, or texting. Cognition and patient-reported outcomes were assessed at baseline (T1), postintervention (T2), and 9 months postbaseline (T3). We assessed enrollment, adherence, and satisfaction. Adherence was defined as ≥80% of participants completing ≥80% of the protocol; satisfaction as ≥6/7 for GMT and texting, and ≥4/5 for ReMind on a self-report Likert question. We used ANOVA, reliable change indices, and qualitative analytics.

Thirty-nine participants were eligible and 33 prospectively enrolled for the study; an 85% enrollment (17-GMT, 8-ReMind, 8-texting; 46.8 median age, 64.8 months from diagnosis, 55% had astrocytoma, and 76% had prior radiotherapy). Eighty-two percent of GMT (adequate), 100% of texting (adequate), and for ReMind 33% of retraining and 50% of compensation (inadequate) completed ≥80% of the protocol. GMT (mean: 6.75/7) and ReMind (mean: 4.5/5) satisfaction were adequate, and texting (mean: 4.5/7) was inadequate. Working memory improved from T1-to-T2 (P = .02, η² = 0.32) in 26% of the GMT group.

GMT demonstrates adequate feasibility, satisfaction, and may yield improvements in working memory, while texting and ReMind had challenges in acceptability or feasibility. Individual (tele) GMT warrants further investigation in LrGG.

## Linked entities

- **Diseases:** astrocytoma (MONDO:0019781)

## Full-text entities

- **Genes:** IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}
- **Diseases:** psychiatrically (MESH:D001523), neuropsychological impairment (MESH:D060825), cancer (MESH:D009369), psychosis (MESH:D011618), COVID (MESH:D000086382), diabetes (MESH:D003920), Glioma (MESH:D005910), meningioma (MESH:D008579), damage to the brain (MESH:D001925), seizure (MESH:D012640), astrocytoma (MESH:D001254), glioblastoma (MESH:D005909), psychiatrically gravely (MESH:D006111), Cognitive impairments (MESH:D003072), memory impairments (MESH:D008569), brain cancer (MESH:D001932), GMT (MESH:D000095027), suicidal ideation (MESH:D001072), smoking (MESH:D015208), depression (MESH:D003866), oligodendroglioma (MESH:D009837), fatigue (MESH:D005221), executive dysfunction (MESH:D006331)
- **Chemicals:** GMT (-), caffeine (MESH:D002110)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965652/full.md

---
Source: https://tomesphere.com/paper/PMC12965652